Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8722502 | Digestive and Liver Disease | 2017 | 21 Pages |
Abstract
Most patients reported a high personal and a moderate companions' burden. Having the possibility of effective single dose intravenous therapy was of great importance. Patients' perspective provides key information for evaluating the indirect costs of anemia treatment in IBD which, according to the health technology assessment approach, could be useful in a patient centered decision making process.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Sonja Milovanovic, Franco Scaldaferri, Stefania Canarecci, Flavia Kheiraoui, Giulia Ciancarella, Chiara de Waure, Agnese Collamati, Elisa Schiavoni, Antonio Gasbarrini, Stefania Boccia, Andrea Poscia,